(1) Intestinal Organoid Models for APC LOH
(1) APC LOH肠类器官模型
基本信息
- 批准号:9172584
- 负责人:
- 金额:$ 23.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAllelesApcMin/+ miceApoptosisCell SeparationCellsClustered Regularly Interspaced Short Palindromic RepeatsColon CarcinomaCytokinesisDataDetectionDevelopmentDiphtheria ToxinDiploid CellsEngineeringEnvironmental Risk FactorEventFailureFrequenciesGene ExpressionGenesGeneticGenetic PolymorphismGenetic studyGenome StabilityGenomic InstabilityGenomicsGrowthHeterozygoteIndividualIntestinal CancerIntestinesLesionLinkLoss of HeterozygosityMitosisModelingMolecular ProfilingMucous MembraneMutationNatureOrganoidsPloidiesPopulationPremalignantProcessRegulatory PathwayReporterResistanceRiskRoleSecretory CellSignal TransductionStem cellsSystemTP53 geneTimeTissuesTumor Suppressor Genesabstractingcancer cellcancer preventioncancer riskcancer stem celldiphtheria toxin receptorhigh riskinsightmouse modelmutantnovelsingle cell analysistargeted agenttranscriptometumor progression
项目摘要
Project Summary/Abstract
A critical step in colon cancer development occurs when a cell within a field of Apc-
heterozygote mutant cells undergoes Apc loss of heterozygosity (LOH). Understanding
the mechanism and cellular consequences of an Apc LOH event could provide important
information on how this event might be suppressed to reduce cancer risk. Critical
questions that remain unanswered include: Do the events leading to Apc LOH include a
failure of cytokinesis? Are all cells that undergo an LOH event at equivalent risk of
progression? What genetic and environmental factors can impact Apc LOH?
We propose to develop an intestinal organoid system as a malleable experimental
platform to study Apc LOH. We will utilize intestinal organoids generated from ESCs since
these “mini-intestines” can be genetically manipulated and grown in the quantities
necessary to detect the relatively rare Apc LOH event. We propose to develop this
organoid system to study Apc LOH in real-time by linking the ApcMin allele to GFP and the
Apc-wild type allele to an RFP reporter and the diphtheria toxin receptor (DTR). We will
use these organoids to enumerate and isolate cells that have undergone Apc LOH. We
will initially determine how p16 and p53 affect Apc LOH frequency, but envision these
organoids being used to assess the impact of a broad range of mutations and
polymorphisms. We will study the nature of cells emerging from an Apc LOH event,
focusing on their proliferative capacity and their relationship to normal ISCs and cancer
stem cells. Finally, we will assess the role of tetraploid cells as precursors for Apc LOH
and determine if a novel mitosis-targeting agent that selectively induces apoptosis of
tetraploid cells can reduce the frequency of Apc LOH.
These exploratory studies are anticipated to establish an experimental system for
studying a critical event in colon cancer development; the emergence of Apc-mutant cells
in a pre-malignant tissue field. In the long term we envision establishing an integrated
experimental pipeline to understand how environmental and genetic factors impact Apc
LOH, how cells that have undergone Apc LOH progress to cancer stem cells, and
ultimately, how an individual's risk of colon cancer risk can be reduced.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHARLES A. GIARDINA其他文献
CHARLES A. GIARDINA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHARLES A. GIARDINA', 18)}}的其他基金
Development of ESC-derived Intestinal Cells for Colon Cancer Research
用于结肠癌研究的 ESC 衍生肠细胞的开发
- 批准号:
8516474 - 财政年份:2012
- 资助金额:
$ 23.22万 - 项目类别:
Development of ESC-derived Intestinal Cells for Colon Cancer Research
用于结肠癌研究的 ESC 衍生肠细胞的开发
- 批准号:
8302854 - 财政年份:2012
- 资助金额:
$ 23.22万 - 项目类别:
Targeting p53 for colon cancer treatment & prevention
靶向 p53 治疗结肠癌
- 批准号:
7535437 - 财政年份:2008
- 资助金额:
$ 23.22万 - 项目类别:
Targeting p53 for colon cancer treatment & prevention
靶向 p53 治疗结肠癌
- 批准号:
7679510 - 财政年份:2008
- 资助金额:
$ 23.22万 - 项目类别:
Mustard Gas Exposure and Carcinogenesis of the Lung
芥子气暴露与肺部致癌
- 批准号:
6875435 - 财政年份:2006
- 资助金额:
$ 23.22万 - 项目类别:
Mustard Gas Exposure and Carcinogenesis of the Lung
芥子气暴露与肺部致癌
- 批准号:
7262617 - 财政年份:2006
- 资助金额:
$ 23.22万 - 项目类别:
COLON CANCER CHEMOPREVENTIVE AGENTS AND APOPTOSIS
结肠癌化学预防剂和细胞凋亡
- 批准号:
6626618 - 财政年份:1999
- 资助金额:
$ 23.22万 - 项目类别:
COLON CANCER CHEMOPREVENTIVE AGENTS AND APOPTOSIS
结肠癌化学预防剂和细胞凋亡
- 批准号:
6137689 - 财政年份:1999
- 资助金额:
$ 23.22万 - 项目类别:
COLON CANCER CHEMOPREVENTIVE AGENTS AND APOPTOSIS
结肠癌化学预防剂和细胞凋亡
- 批准号:
2728443 - 财政年份:1999
- 资助金额:
$ 23.22万 - 项目类别:
COLON CANCER CHEMOPREVENTIVE AGENTS AND APOPTOSIS
结肠癌化学预防剂和细胞凋亡
- 批准号:
6342113 - 财政年份:1999
- 资助金额:
$ 23.22万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 23.22万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 23.22万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 23.22万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 23.22万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 23.22万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 23.22万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 23.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 23.22万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 23.22万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 23.22万 - 项目类别: